The FDA has ordered BioNTech to immediately halt its Phase I/II trial of malaria vaccine candidate BNT165e, pending changes.
BioNTech said in a regulatory filing on Tuesday the U.S. Food and Drug Administration has placed a clinical hold on an ...
Innovative research approaches are therefore urgently needed to achieve long-term progress in prevention and ...
Epigenetics are one of life's primary drivers of adaptations. They are why human beings who live at high altitude have more ...
BioNTech SE (NASDAQ:BNTX) said on Tuesday, that the U.S. Food and Drug Administration informed of a clinical hold on the ...
P. falciparum is introduced into the body via a mosquito bite. The parasite grows and multiplies first in the liver, then uses human red blood cells as a nursery in which to replicate and release ...
BioNTech's early-to-mid stage trial of an experimental malaria vaccine has been put on a clinical hold by the U.S. Food and ...
Health authorities are conducting tests in regions of DR Congo affected by a mystery disease that has killed 60 people.
"Our research shows that PfSnf2L is essential for P. falciparum to dynamically adjust gene expression," explains Maria Theresia Watzlowik, lead author of the study. "The unique sequence and ...